18 search results for “kanker lentelezing” in the Public website
-
Tracing cancer with a simple blood test
Thanks in part to the persistence of a Leiden research group, cancer could be detected in the near future with just a single drop of blood. Not only can the diagnosis be determined at an earlier stage, but the blood test is also cheap, fast and patient friendly. The first results of this method seem…
-
Small molecule inhibitors of Nicotinamide N-Methyltransferase (NNMT)
NNMT wordt beschouwd als een nieuw potentieel farmacologisch doelwit in de behandeling van een verscheidenheid van kankers, stofwisselingsziekten en andere pathologieën. Het toenemend aantal publicaties waarin de rol van NNMT bij ziekten wordt opgehelderd, heeft op zijn beurt de ontwikkeling van krachtige…
-
The chemistry behind cancer drugs: searching for fewer side effects
PhD candidate Dennis Wander searches for the best of both worlds. That is to say: a cancer drug that is effective and also has minimal side effects. To this end, he makes new molecules inspired by two existing medicines. And not without result: ‘We have created a new variant that is very promising.’…
-
NeCEN
With the powerful electron microscopes at NeCEN we study abnormalities in cells of blood vessels in cardiovascular disease, the interaction between pathogens and hosts in infectious diseases, molecular processes that cause cancer and the interaction between drugs and target proteins. Drug development…
-
Medical Delta professor Lioe-Fee de Geus-Oei: 'We work together for the patient'
Professor of Radiology Lioe-Fee de Geus-Oei was already a professor at LUMC and the University of Twente. As Medical Delta professor, she has now also been appointed at Delft University of Technology. 'Talking with people from other disciplines always makes me immensely humble, because they look at…
-
Oncode Accelerator
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process. Leiden University, the LUMC and other partners will implement this new way…
- Career prospects
-
In Memoriam professor Wim Jiskoot (1961-2021)
Afgelopen zondagavond, 22 augustus, is na een kort ziekbed onze zeer gewaardeerde collega professor Wim Jiskoot, Hoogleraar Technologie van toediening van medicijnen, overleden. Wim werd twee weken geleden onverwachts geconfronteerd met het feit dat hij een vergevorderd stadium van kanker had, waarvoor…
-
Renewable Energy
The transition to new and renewable energy sources should be completed by 2050. Researchers in various disciplines at Leiden University are conducting unique research that will help us make this transition and reduce CO2 emissions.
-
Shaping innate immune responses: mechanisms that control type I interferon production
PhD defence
-
Cutaneous CD30-positive lymphoproliferations: Therapeutic strategies and prognostic factors
PhD defence
-
Molecular approaches to identify cancer T cell antigens and improve immunogenicity
PhD defence
-
Joining hands to advance Dutch microscopy
Advanced microscopy to understand life and fight disease: that’s the goal of the new NL-BioImaging network that will develop and integrate state-of-the-art microscopy technologies and services. Researchers from all Dutch universities, including Leiden University and the Leiden University Medical Centre,…
-
Prognostic factors in distinct melanoma types
PhD defence
-
Optimizing clinical management of T1 colorectal cancer
PhD defence
-
Reproductive and sexual health care in oncology
PhD defence
-
How T cells talk to the neighborhood
PhD defence
-
Tumor-specific targets for imaging in vulvar cancer
PhD defence